FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912605023> ?p ?o ?g. }

• W2912605023 abstract "A promising tool for noninvasive disease monitoring is analysis of circulating tumor DNA (ctDNA). Healthy individuals carry 1-10 ng/ml of cell-free DNA (cfDNA) in the blood; in oncology patients, ctDNA, which is released from tumor cells, comprises a fraction of the cfDNA and carries tumor-specific alterations, such as mutations, translocations, and copy number alterations. Most ctDNA assays lack robust translocation detection capabilities, since they are designed for adult cancers, which are commonly characterized by mutations and copy number alterations. Even assays that are designed specifically for translocation detection have inherent limitations. They are often PCR-based with laborious methods. First, the patient’s primary tumor sample is sequenced to determine the unique sequence across the translocation breakpoint. This is followed by design of patient-specific primers that can only be used for that individual patient. We sought to design an off-the-shelf, broadly applicable ctDNA assay for translocation detection across pediatric Ewing sarcoma (ES), osteosarcoma (OS), rhabdomyosarcoma (RMS), and synovial sarcoma (SS). Recent work by our collaborators at Stanford University led to the development of CAncer Personalized Profiling by deep Sequencing (CAPP-Seq), a method capable of ultraspecific and ultrasensitive detection of ctDNA. Utilizing COSMIC and TCGA data, recent sequencing publications defining the landscape of pediatric sarcomas, and our own in-house sequencing data, we designed a pediatric sarcoma CAPP-Seq selector. This selector is comprised of biotinylated oligonucleotides that tile across the introns where translocation breakpoints occur in these pediatric sarcomas. The selector is applied to a sequencing library prepared from patient cfDNA to enrich for the genomic regions of interest via hybrid capture. The resulting enriched library undergoes next-generation sequencing to allow for detection and quantification of circulating tumor DNA. We have isolated cfDNA from pediatric sarcoma patients and found that their cfDNA levels are higher than levels found in adult oncology patients and healthy individuals, likely due to a large fraction of contributing ctDNA. We have applied our selector to pretreatment plasma samples from 5 EWS patients, 2 OS patients, 4 RMS patients, and 1 SS patient. We detected translocations in 10/12 of these samples. Tumor was available for 7/12 of these patients, and we were able to confirm our plasma results by whole-genome sequencing of the tumor, as a validation of our findings. Additionally, we have applied our selector to serial plasma samples collected over the course of treatment and found that ctDNA levels correlate with clinical status. We have detected translocations at allelic frequencies Citation Format: Avanthi Tayi Shah, Tej D. Azad, Jake J. Chabon, Marcus Breese, Bogdan Tanasa, Aviv Spillinger, Stanley G. Leung, Maximilian Diehn, Ash A. Alizadeh, E. Alejandro Sweet-Cordero. Quantitating circulating tumor DNA in translocation-positive sarcoma patients using CAPP-Seq [abstract]. In: Proceedings of the AACR Special Conference: Pediatric Cancer Research: From Basic Science to the Clinic; 2017 Dec 3-6; Atlanta, Georgia. Philadelphia (PA): AACR; Cancer Res 2018;78(19 Suppl):Abstract nr B49." @default.
• W2912605023 created "2019-02-21" @default.
• W2912605023 creator A5001873561 @default.
• W2912605023 creator A5007420876 @default.
• W2912605023 creator A5018574547 @default.
• W2912605023 creator A5026362990 @default.
• W2912605023 creator A5031495533 @default.
• W2912605023 creator A5033202151 @default.
• W2912605023 creator A5061355669 @default.
• W2912605023 creator A5070884825 @default.
• W2912605023 creator A5075206464 @default.
• W2912605023 creator A5090288786 @default.
• W2912605023 date "2018-10-01" @default.
• W2912605023 modified "2023-10-18" @default.
• W2912605023 title "Abstract B49: Quantitating circulating tumor DNA in translocation-positive sarcoma patients using CAPP-Seq" @default.
• W2912605023 doi "https://doi.org/10.1158/1538-7445.pedca17-b49" @default.
• W2912605023 hasPublicationYear "2018" @default.
• W2912605023 type Work @default.
• W2912605023 sameAs 2912605023 @default.
• W2912605023 citedByCount "0" @default.
• W2912605023 crossrefType "proceedings-article" @default.
• W2912605023 hasAuthorship W2912605023A5001873561 @default.
• W2912605023 hasAuthorship W2912605023A5007420876 @default.
• W2912605023 hasAuthorship W2912605023A5018574547 @default.
• W2912605023 hasAuthorship W2912605023A5026362990 @default.
• W2912605023 hasAuthorship W2912605023A5031495533 @default.
• W2912605023 hasAuthorship W2912605023A5033202151 @default.
• W2912605023 hasAuthorship W2912605023A5061355669 @default.
• W2912605023 hasAuthorship W2912605023A5070884825 @default.
• W2912605023 hasAuthorship W2912605023A5075206464 @default.
• W2912605023 hasAuthorship W2912605023A5090288786 @default.
• W2912605023 hasConcept C104317684 @default.
• W2912605023 hasConcept C121608353 @default.
• W2912605023 hasConcept C129312508 @default.
• W2912605023 hasConcept C138626823 @default.
• W2912605023 hasConcept C142724271 @default.
• W2912605023 hasConcept C206936463 @default.
• W2912605023 hasConcept C2776910622 @default.
• W2912605023 hasConcept C2778256501 @default.
• W2912605023 hasConcept C2993561819 @default.
• W2912605023 hasConcept C502942594 @default.
• W2912605023 hasConcept C51679486 @default.
• W2912605023 hasConcept C54355233 @default.
• W2912605023 hasConcept C552990157 @default.
• W2912605023 hasConcept C70721500 @default.
• W2912605023 hasConcept C71924100 @default.
• W2912605023 hasConcept C86803240 @default.
• W2912605023 hasConceptScore W2912605023C104317684 @default.
• W2912605023 hasConceptScore W2912605023C121608353 @default.
• W2912605023 hasConceptScore W2912605023C129312508 @default.
• W2912605023 hasConceptScore W2912605023C138626823 @default.
• W2912605023 hasConceptScore W2912605023C142724271 @default.
• W2912605023 hasConceptScore W2912605023C206936463 @default.
• W2912605023 hasConceptScore W2912605023C2776910622 @default.
• W2912605023 hasConceptScore W2912605023C2778256501 @default.
• W2912605023 hasConceptScore W2912605023C2993561819 @default.
• W2912605023 hasConceptScore W2912605023C502942594 @default.
• W2912605023 hasConceptScore W2912605023C51679486 @default.
• W2912605023 hasConceptScore W2912605023C54355233 @default.
• W2912605023 hasConceptScore W2912605023C552990157 @default.
• W2912605023 hasConceptScore W2912605023C70721500 @default.
• W2912605023 hasConceptScore W2912605023C71924100 @default.
• W2912605023 hasConceptScore W2912605023C86803240 @default.
• W2912605023 hasLocation W29126050231 @default.
• W2912605023 hasOpenAccess W2912605023 @default.
• W2912605023 hasPrimaryLocation W29126050231 @default.
• W2912605023 hasRelatedWork W183894410 @default.
• W2912605023 hasRelatedWork W1994207254 @default.
• W2912605023 hasRelatedWork W2005646293 @default.
• W2912605023 hasRelatedWork W2017793175 @default.
• W2912605023 hasRelatedWork W2063120225 @default.
• W2912605023 hasRelatedWork W2086941386 @default.
• W2912605023 hasRelatedWork W2110994974 @default.
• W2912605023 hasRelatedWork W2357866422 @default.
• W2912605023 hasRelatedWork W2912605023 @default.
• W2912605023 hasRelatedWork W910787821 @default.
• W2912605023 isParatext "false" @default.
• W2912605023 isRetracted "false" @default.
• W2912605023 magId "2912605023" @default.
• W2912605023 workType "article" @default.